BIOMERICA INC

BMRA · XNAS

CIK 73290fmd_09D6BR4ZDKT87ZVJMR2S8E8WG3Manufacturing · In Vitro & In Vivo Diagnostic SubstancesTemplate: Standard

Coverage: Jun 01, 2010 to Aug 31, 2026, 65 periods

AI-written

A model wrote this from the company's own SEC filings and our standardized facts. It is not reported fact, not an analyst's estimate, not a rating and not investment advice. Every claim shows what it rests on.